Publication Date
| In 2025 | 0 |
| Since 2024 | 0 |
| Since 2021 (last 5 years) | 0 |
| Since 2016 (last 10 years) | 1 |
| Since 2006 (last 20 years) | 1 |
Descriptor
| Children | 3 |
| Clinical Diagnosis | 3 |
| Genetics | 3 |
| Medical Research | 3 |
| Etiology | 2 |
| Acquired Immunodeficiency… | 1 |
| Adults | 1 |
| Autism | 1 |
| Cancer | 1 |
| Child Development | 1 |
| Correlation | 1 |
| More ▼ | |
Publication Type
| Reports - Descriptive | 2 |
| Journal Articles | 1 |
Education Level
Audience
Location
Laws, Policies, & Programs
Assessments and Surveys
What Works Clearinghouse Rating
Direct linkTan, Mei; Bowers, Megan; Thuma, Phil; Grigorenko, Elena L. – New Directions for Child and Adolescent Development, 2020
Efavirenz (EFV) is a well-known, effective anti-retroviral drug long used in first-line treatment for children and adults with HIV and HIV/AIDS. Due to its narrow window of effective concentrations, between 1 and 4 µg/mL, and neurological side effects at supratherapeutic levels, several investigations into the pharmacokinetics of the drug and its…
Descriptors: Drug Therapy, Outcomes of Treatment, Acquired Immunodeficiency Syndrome (AIDS), Neurology
Peer reviewedSafyer, Andrew W.; Miller, Robert W. – Journal of School Health, 1977
Epidemiologic research has revealed a wide spectrum of etiologic information concerning childhood cancer. (MB)
Descriptors: Cancer, Children, Clinical Diagnosis, Diseases
Download full textNational Inst. of Child Health and Human Development (NIH), Bethesda, MD. Mental Retardation and Developmental Disabilities Branch. – 2001
This report highlights some of the projects supported by the Mental Retardation and Developmental Disabilities (MRDD) Branch of the Center for Research for Mothers and Children at the National Institute of Child Health and Human Development since its last report in January 1997. The MRDD Branch provides support for research, research training,…
Descriptors: Adults, Autism, Children, Clinical Diagnosis
